Scientific paper - Other
Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
Diabetology, 4 (2023), 4; 553-559. https://doi.org/10.3390/diabetology4040049

Golčić, Marin; Belančić, Andrej

Cite this document

Golčić, M. & Belančić, A. (2023). Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?. Diabetology, 4. (4), 553-559. doi: 10.3390/diabetology4040049

Golčić, Marin and Andrej Belančić. "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?." Diabetology, vol. 4, no. 4, 2023, pp. 553-559. https://doi.org/10.3390/diabetology4040049

Golčić, Marin and Andrej Belančić. "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?." Diabetology 4, no. 4 (2023): 553-559. https://doi.org/10.3390/diabetology4040049

Golčić, M. and Belančić, A. (2023) 'Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?', Diabetology, 4(4), pp. 553-559. doi: 10.3390/diabetology4040049

Golčić M, Belančić A. Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?. Diabetology [Internet]. 2023 December 07 [cited 2024 June 16];4(4):553-559. doi: 10.3390/diabetology4040049

M. Golčić and A. Belančić, "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?", Diabetology, vol. 4, no. 4, pp. 553-559, December 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:421839. [Accessed: 16 June 2024]